BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2531607)

  • 1. Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
    Pinquier JL; Urien S; Chaumet-Riffaud P; Tillement JP
    Br J Clin Pharmacol; 1989 Nov; 28(5):587-92. PubMed ID: 2531607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
    Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP
    Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the rat blood-brain barrier. Drug binding to lipoproteins does not limit the transfer of drug.
    Urien S; Pinquier JL; Paquette B; Chaumet-Riffaud P; Kiechel JR; Tillement JP
    J Pharmacol Exp Ther; 1987 Jul; 242(1):349-53. PubMed ID: 2956411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.
    Urien S; Morin D; Renouard A; Rocher I; Tillement JP
    Eur J Clin Pharmacol; 1988; 34(4):381-5. PubMed ID: 2900145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein.
    Urien S; Morin D; d'Athis P; Coulomb B; Tillement JP
    J Clin Pharmacol; 1988 May; 28(5):458-62. PubMed ID: 3392244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
    Baruzzi A; Contin M; Perucca E; Albani F; Riva R
    Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective binding of isradipine to human plasma proteins.
    Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T
    Chirality; 1995; 7(3):167-72. PubMed ID: 7794694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of nifedipine.
    Otto J; Lesko LJ
    J Pharm Pharmacol; 1986 May; 38(5):399-400. PubMed ID: 2872322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isradipine and darodipine on serotonergic system of the rat brain.
    Gaggi R; Dall'Olio R; Roncada P; Gianni AM
    Pharmacol Biochem Behav; 1995; 51(2-3):183-7. PubMed ID: 7545305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
    Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine in children with cancer: impact of age, chemotherapy and other factors on protein binding.
    Mashayekhi SO; Hain RD; Buss DC; Routledge PA
    J Pain Palliat Care Pharmacother; 2007; 21(4):5-12. PubMed ID: 18032310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
    Urien S; Albengres E; Pinquier JL; Tillement JP
    Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the plasma protein binding of theophylline in health.
    Buss D; Leopold D; Smith AP; Routledge PA
    Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX; Cao LS; Samii K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
    MacKichan JJ; Zola EM
    Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.